Company profile: CellforCure
1.1 - Company Overview
Company description
- Provider of advanced therapy medicinal product expertise as a key industrial and innovative player in the field.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to CellforCure
HTG Molecular
HQ: United States
Website
- Description: Provider of assays and reagent systems for gene expression analysis, including the HTG Transcriptome Panel for full transcriptome profiling to support drug and companion diagnostic discovery; HTG EpiEdgeSeq for RNA modification profiling; and a Drug Discovery Engine and pipeline targeting RNA‑Modifying Proteins across oncology, autoimmune, neurodegenerative, and rare diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full HTG Molecular company profile →
Orna Therapeutics
HQ: United States
Website
- Description: Provider of engineered circular RNA therapeutics and tools: isCAR therapy using oRNA and proprietary LNPs to modify immune cells for tumor control without lymphodepletion; oRNA-based dystrophin replacement via non-viral delivery to liver and muscle; next-generation vaccines with Merck using oRNA/LNP; and FoRCE for high-throughput oRNA sequence evaluation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Orna Therapeutics company profile →
e-Zyvec
HQ: France
Website
- Description: Provider of molecular biology solutions for academic and industrial scientists conducting research with genetic engineering applications; a biotechnology company specializing in genetic engineering, founded in 2016 and headquartered in Loos, France.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full e-Zyvec company profile →
Krystal Biotech
HQ: United States
Website
- Description: Provider of gene therapies, including FDA-approved VYJUVEK for delivering missing or defective genes to the skin; with focus on Autosomal Recessive Congenital Ichthyosis, Netherton Syndrome, Cystic Fibrosis, and Alpha-1 Antitrypsin Deficiency; and oncology development using a modified HSV-1 vector to deliver IL-12 and IL-2 to the tumor microenvironment for immune-mediated tumor clearance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Krystal Biotech company profile →
Biocartis
HQ: Switzerland
Website
- Description: Provider of a diagnostics technology platform for multiplexed detection of bio‑analytes, focused on integrated molecular and immunodiagnostics via a proprietary micro‑technology platform. Products include the Idylla fully automated sample‑to‑result real‑time PCR system for molecular diagnostics from various biological samples, and assays such as APIS ESR1, Idylla BRAF, GeneFusion (research use), ctEGFR, and NRAS‑BRAF‑EGFR S492R.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biocartis company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for CellforCure
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to CellforCure
2.2 - Growth funds investing in similar companies to CellforCure
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for CellforCure
4.2 - Public trading comparable groups for CellforCure
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →